Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis
ConclusionInfliximab was not efficient in reducing depressive symptoms according to the HAM-D, only when the patients already had increased inflammatory genes, including TNF and C-reactive protein (CRP).
Source: Pharmacology Biochemistry and Behavior - Category: Biochemistry Source Type: research
More News: Biochemistry | Databases & Libraries | Depression | Drugs & Pharmacology | Genetics | Politics | Remicade | Science | Statistics | Study | UK Health